{{Rsnum
|rsid=5569
|Gene=SLC6A2
|Chromosome=16
|position=55697923
|Orientation=minus
|GMAF=0.2691
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC6A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.9 | 49.6 | 18.6
| HCB | 53.4 | 40.6 | 6.0
| JPT | 67.3 | 28.3 | 4.4
| YRI | 87.5 | 11.8 | 0.7
| ASW | 67.9 | 30.4 | 1.8
| CHB | 53.4 | 40.6 | 6.0
| CHD | 43.5 | 49.1 | 7.4
| GIH | 55.0 | 36.0 | 9.0
| LWK | 86.1 | 13.9 | 0.0
| MEX | 31.0 | 50.0 | 19.0
| MKK | 87.6 | 12.4 | 0.0
| TSI | 43.6 | 43.6 | 12.9
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19727679
|Title=Further evidence of association between amphetamine response and SLC6A2 gene variants
}} (Associated with [[ADHD]].)

{{PMID Auto
|PMID=20863575
|Title=Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD
}}

{{PMID Auto
|PMID=17630229
|Title=Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups.
}}

{{PMID Auto
|PMID=17917281
|Title=No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population.
}}

{{PMID Auto
|PMID=17994190
|Title=Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.
}}

{{PMID Auto
|PMID=18081710
|Title=Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression.
|OA=1
}}

{{PMID Auto
|PMID=18180394
|Title=Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans.
|OA=1
}}

{{PMID Auto
|PMID=18779921
|Title=The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population.
}}

{{PMID Auto
|PMID=18937309
|Title=Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study.
|OA=1
}}

{{PMID Auto
|PMID=19693267
|Title=Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene.
|OA=1
}}

{{PMID Auto
|PMID=20008943
|Title=Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.
|OA=1
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{PMID Auto
|PMID=23442739
|Title=Psychomotor depressive symptoms may differentially respond to venlafaxine
}}

{{PMID Auto
|PMID=22727709
|Title=Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder.
}}

{{PMID Auto
|PMID=23648227
|Title=Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.
}}

{{PMID Auto
|PMID=23733030
|Title=Pharmacogenetics in major depression: a comprehensive meta-analysis.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}